Understanding Type 2 Diabetes

Type 2 diabetes arises when the pancreas fails to produce sufficient insulin to regulate blood glucose levels. The treatment for this condition represents a significant financial opportunity for the pharmaceutical sector.

This paragraph will result in an indented block of text, typically used for quoting other text.

Section 1.1 Treatment Options

There are two primary categories of medications for Type 2 diabetes. The most recognized is insulin, which, while not the initial treatment for many patients, is often necessary when other first-line medications are ineffective.

Image licensed via freepik.com

The initial treatment options, referred to as “non-insulin therapeutics,” encompass drugs such as metformin, glipizide, and miglitol. These medications delay the need for insulin by stimulating the pancreas to produce more insulin, slowing sugar absorption in the gut, or decreasing the liver’s glucose output, while also enhancing the body’s responsiveness to insulin.

According to Fortune Business Insights, the global diabetes market is projected to reach $50 billion, with forecasts suggesting it could soar to nearly $80 billion by 2026. The healthcare expenses associated with diabetes are staggering; in the United States, the American Diabetes Association estimates the annual cost exceeds $327 billion, with individuals often spending over $16,000 yearly on healthcare.

Section 1.2 The Onset of Diabetes

Many individuals are taken aback when diagnosed with Type 2 diabetes. They may regularly check their fasting blood glucose, which appears normal until it begins to rise with age, eventually leading to pre-diabetes. Despite efforts to “eat less and exercise more,” blood glucose levels can escalate into the diabetic range, prompting the need for medications or insulin.

Image licensed via freepik.com

A hypothetical graph might show an individual’s fasting blood glucose readings from ages 20 to 46. Ideally, these levels should remain in the green zone of 80 to 99 mg/dl. When levels hit 100 mg/dl, the individual enters the pre-diabetes category, and a diagnosis of Type 2 diabetes occurs at 126 mg/dl or higher. Many experience fluctuations in fasting glucose levels for years before they become problematic, despite consistent diet and exercise routines.

Insulin Resistance: A Key Factor

Insulin resistance occurs when the body’s cells become less responsive to insulin, necessitating increased insulin production to manage blood glucose. When the pancreas can no longer keep up, elevated blood sugar levels can lead to severe health consequences, including tissue and nerve damage, heart disease, and even death.

Measuring fasting insulin levels can serve as a crucial early indicator for diabetes. A simple blood test taken alongside glucose measurements can reveal whether insulin resistance is developing. If fasting insulin levels rise, it often means more insulin is needed to maintain glucose control, which may not be apparent when only monitoring blood glucose levels.

Graph created by the author

By the time an individual reaches their late twenties, rising insulin levels may indicate a predisposition to diabetes, even if blood glucose readings remain normal. Interventions such as intermittent fasting or a low-carb diet could help regulate insulin levels before diabetes develops.

The Economic and Health Impact

Preventing diabetes could lead to substantial savings in healthcare costs and improve public health outcomes. Governments with healthcare systems should recognize the benefits of preventive measures, as they would alleviate the financial burden on their systems.

However, pharmaceutical companies may not be eager to support such initiatives, as their priority lies with shareholder returns rather than public health. While it’s unlikely that industry professionals wish harm upon individuals, the urgency to find cures or preventative measures may not align with their business interests.

The next time you undergo blood tests, consider asking for a fasting insulin test alongside your glucose evaluation. Managing insulin resistance is straightforward and can yield quick results.

Thank you for reading this article; I hope you found it informative.

For more insights, consider joining Medium for access to a range of writers and topics for only about $5.00 a month. I also authored a book on nutrition, metabolism, and weight management, available on Amazon, which delves deeper into these subjects in an accessible way.

Image is property of the author

Chapter 2: The Call for Action

In the video titled "LIVE: Big Pharma, Stop Ripping Off The American People," experts discuss the financial motivations behind pharmaceutical practices and the impact on healthcare.

Another insightful video, "The cancer research that pharmaceutical companies won't fund," explores the reluctance of the industry to support certain preventative health initiatives.